Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative cognitive function after major abdominal surgery in older adults
ChiCTR2400091313Phase 4Not yet recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in post-operative cognitive decline (POCD) and postoperative delirium (POD) (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Incidence of postoperative cognitive dysfunction. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
post-operative cognitive decline (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2400091313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091313.